Bausch Health (BHC)
(Delayed Data from NYSE)
$8.60 USD
-0.06 (-0.69%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $8.61 +0.01 (0.12%) 7:10 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Price, Consensus and EPS Surprise
BHC 8.60 -0.06(-0.69%)
Will BHC be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for BHC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BHC
Will Bausch (BHC) Beat Estimates Again in Its Next Earnings Report?
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
BHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Bausch Health (BHC) is a Strong Momentum Stock
Here's Why Bausch Health (BHC) is a Strong Momentum Stock
Bausch (BHC) Soars 6.4%: Is Further Upside Left in the Stock?
Other News for BHC
Jefferies healthcare analyst holds an analyst/industry conference call
Bausch Health put volume heavy and directionally bearish
Makers Nutrition Founder and CEO Jason Provenzano Stands Triumphant in the 2024 TITAN Business Awards
Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Walgreens Boots Alliance (WBA) and Evolent Health (EVH)
Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC) and Arcus Biosciences (RCUS)